BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21413743)

  • 1. Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane.
    Ambike A; Rosilio V; Stella B; Lepêtre-Mouelhi S; Couvreur P
    Langmuir; 2011 Apr; 27(8):4891-9. PubMed ID: 21413743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
    Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
    Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of gemcitabine affinity for biomembranes by conjugation with squalene: differential scanning calorimetry and Langmuir-Blodgett studies using biomembrane models.
    Castelli F; Sarpietro MG; Micieli D; Stella B; Rocco F; Cattel L
    J Colloid Interface Sci; 2007 Dec; 316(1):43-52. PubMed ID: 17765257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.
    Maksimenko A; Alami M; Zouhiri F; Brion JD; Pruvost A; Mougin J; Hamze A; Boissenot T; Provot O; Desmaële D; Couvreur P
    ACS Nano; 2014 Mar; 8(3):2018-32. PubMed ID: 24555414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
    Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
    Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.
    Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A
    Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
    Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
    Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
    Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting.
    Arias JL; Reddy LH; Couvreur P
    Langmuir; 2008 Jul; 24(14):7512-9. PubMed ID: 18540685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface.
    Sarpietro MG; Rocco F; Micieli D; Ottimo S; Ceruti M; Castelli F
    Int J Pharm; 2010 Aug; 395(1-2):167-73. PubMed ID: 20635474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.
    Couvreur P; Reddy LH; Mangenot S; Poupaert JH; Desmaële D; Lepêtre-Mouelhi S; Pili B; Bourgaux C; Amenitsch H; Ollivon M
    Small; 2008 Feb; 4(2):247-53. PubMed ID: 18247384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
    Rodríguez-Nogales C; Sebastián V; Irusta S; Desmaële D; Couvreur P; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2019 Nov; 144():165-173. PubMed ID: 31546021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment.
    Kushwah V; Agrawal AK; Dora CP; Mallinson D; Lamprou DA; Gupta RC; Jain S
    Pharm Res; 2017 Nov; 34(11):2295-2311. PubMed ID: 28795274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors.
    Rodríguez-Nogales C; Desmaële D; Sebastián V; Couvreur P; Blanco-Prieto MJ
    ChemMedChem; 2021 Dec; 16(24):3730-3738. PubMed ID: 34581019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma.
    Khoury H; Deroussent A; Reddy LH; Couvreur P; Vassal G; Paci A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):71-8. PubMed ID: 17851141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery.
    Sobot D; Mura S; Yesylevskyy SO; Dalbin L; Cayre F; Bort G; Mougin J; Desmaële D; Lepetre-Mouelhi S; Pieters G; Andreiuk B; Klymchenko AS; Paul JL; Ramseyer C; Couvreur P
    Nat Commun; 2017 May; 8():15678. PubMed ID: 28555624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled drug release from polyelectrolyte-drug conjugate nanoparticles.
    Catarata R; Azim N; Bhattacharya S; Zhai L
    J Mater Chem B; 2020 Apr; 8(14):2887-2894. PubMed ID: 32191246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.